Assessing the Impact of Group Therapy Combined with Buprenorphine or Naltrexone on Attendance and/or Life Satisfaction for Patients with Substance Use Disorder

Location

Medical Education Building, LSUHSC-NO

Presentation Date

10-10-2019 10:00 AM

End Date

10-10-2019 12:00 PM

Description

The present study sought to understand the impact group therapy combined with Medication Assisted Treatment (MAT) had on appointment attendance and life satisfaction for those with alcohol use disorder (AUD) and opioid use disorder (OUD) in the Support Wellness Program at the South End Community Health Center. This is a quantitative study of 48 participants with OUD and AUD who are currently prescribed either Buprenophine or Naltrexone, and who either attend group therapy sessions at least once a week or who have never attended a group therapy session. All participants were given a life satisfaction survey to complete. Appointment attendance was tracked for all participants between January 1st, 2019 and July 3rd, 2019. Data analysis for life satisfaction was determined using variance analysis (ANOVA). Patients who attended at least one weekly group therapy session had a higher life satisfaction rating (83.6%) than patients who never attended any group therapy session (73%). Overall, attendance rates for scheduled appointments was higher for patients who attended group therapy sessions (78.1%) compared to those who never attended group therapy sessions (73.1%), but the results were not statistically significant. The results from the questionnaire suggest that group therapy combined with MAT has a positive effect on patients and fosters satisfaction in various domains. Although, no statistical significance was demonstrated for attendance between group therapy participants and non-group therapy participants, further research should be conducted to understand the impact of group therapy on appointment attendance.

Comments

Mentors: Vanessa Ryan, FNP and Elizabeth Davis, MD (South End Community Health Center, Boston, MA)

This document is currently not available here.

Share

COinS
 
Oct 10th, 10:00 AM Oct 10th, 12:00 PM

Assessing the Impact of Group Therapy Combined with Buprenorphine or Naltrexone on Attendance and/or Life Satisfaction for Patients with Substance Use Disorder

Medical Education Building, LSUHSC-NO

The present study sought to understand the impact group therapy combined with Medication Assisted Treatment (MAT) had on appointment attendance and life satisfaction for those with alcohol use disorder (AUD) and opioid use disorder (OUD) in the Support Wellness Program at the South End Community Health Center. This is a quantitative study of 48 participants with OUD and AUD who are currently prescribed either Buprenophine or Naltrexone, and who either attend group therapy sessions at least once a week or who have never attended a group therapy session. All participants were given a life satisfaction survey to complete. Appointment attendance was tracked for all participants between January 1st, 2019 and July 3rd, 2019. Data analysis for life satisfaction was determined using variance analysis (ANOVA). Patients who attended at least one weekly group therapy session had a higher life satisfaction rating (83.6%) than patients who never attended any group therapy session (73%). Overall, attendance rates for scheduled appointments was higher for patients who attended group therapy sessions (78.1%) compared to those who never attended group therapy sessions (73.1%), but the results were not statistically significant. The results from the questionnaire suggest that group therapy combined with MAT has a positive effect on patients and fosters satisfaction in various domains. Although, no statistical significance was demonstrated for attendance between group therapy participants and non-group therapy participants, further research should be conducted to understand the impact of group therapy on appointment attendance.